N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-[[[5-(2-噻吩基)-3-吡啶基]羰基]氨基]苯甲酰胺结构式
|
常用名 | N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-[[[5-(2-噻吩基)-3-吡啶基]羰基]氨基]苯甲酰胺 | 英文名 | ALW-II-41-27 |
|---|---|---|---|---|
| CAS号 | 1186206-79-0 | 分子量 | 607.68900 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C32H32F3N5O2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
用途ALW-II-41-27 是一种新颖的 Eph receptor 抑制剂,用于癌症研究。 |
| 中文名 | N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-[[[5-(2-噻吩基)-3-吡啶基]羰基]氨基]苯甲酰胺 |
|---|---|
| 英文名 | N-[5-[[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]-2-methylphenyl]-5-thiophen-2-ylpyridine-3-carboxamide |
| 英文别名 | 更多 |
| 描述 | ALW-II-41-27是 Eph 家族酪氨酸激酶抑制剂,抑制Eph2的 IC50为11 nM。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
IC50: 11 nM (Eph2)[1] |
| 体外研究 | ALW-II-41-27抑制用EphA3,Kit,Fms,KDR,FLT1,FGR,Src,Lyn,Bmx和Bcr-Abl的Tel融合转化的Ba/F3细胞,EC50低于500nM。 ALW-II-41-27显示出与Bcr-Abl的交叉反应性。 ALW-II-41-27抑制b-raf,CSF1R,DDR1,DDR2,EphA2,EphA5,EphA8,EphB1,EphB2,EphB3,Frk,Kit,Lck,p38α,p38β,PDGFRα,PDGFRβ和Raf1等多种证实如何引入噻吩基团对激酶选择性产生巨大影响[1]。 |
| 参考文献 |
| 分子式 | C32H32F3N5O2S |
|---|---|
| 分子量 | 607.68900 |
| 精确质量 | 607.22300 |
| PSA | 112.79000 |
| LogP | 7.42320 |
| InChIKey | HYWXBDQAYLPMIX-UHFFFAOYSA-N |
| SMILES | CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1 |
| 储存条件 | 2-8℃ |
| 上游产品 2 | |
|---|---|
| 下游产品 0 | |
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:Primary qHTS assay for small molecule inhibitors of Inositol hexaphosphate kinase 1 (...
来源:NCGC
External Id:IP6K1-p1
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Cytochrome P450 family 3 subfamily A member 4 (CYP3A4) small molecule antagonists: lu...
来源:NCGC
External Id:CYP3A4437
|
|
实验名称:Cytochrome P450 family 2 subfamily D member 6 (CYP2D6) small molecule antagonists: lu...
来源:NCGC
External Id:CYP2D6395
|
|
实验名称:Inhibition of Abl expressed in mouse BA/F3 cells
来源:ChEMBL
靶标:Tyrosine-protein kinase ABL1
External Id:CHEMBL1058295
|
|
实验名称:Cytochrome P450 family 2 subfamily C member 9 (CYP2C9) small molecule antagonists: lu...
来源:NCGC
External Id:CYP2C9536
|
|
实验名称:Cytotoxicity counterscreen for inhibitors of SARS-CoV-2 cell entry
来源:NCGC
靶标:N/A
External Id:TRND-SARS-CoV-2-cytotox-48hr
|
|
实验名称:Fluorescence polarization to screen for inhibitor that competite the binding of FadD2...
来源:Broad Institute
靶标:FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE)
External Id:2147-01_Inhibitor_SinglePoint_HTS_Activity
|
|
实验名称:Inhibition of Bcr-Abl expressed in mouse BA/F3 cells
来源:ChEMBL
靶标:Breakpoint cluster region protein
External Id:CHEMBL1058291
|
| hms2043h01 |
| hms2218g07 |
| cs-1203 |
| alw-ii-41-27 |